Mass spectrometric analysis of cerebrospinal fluid protein for glioma and its clinical application.
Liu J, Yu J, Shen H, Zhang J, Liu W, Chen Z, He S, Zheng S.
Contemp Oncol (Pozn). 2014;18(2):100-5. doi: 10.5114/wo.2014.40455. Epub 2014 Jun 3.
PMID:24966792
Discrepancies between qualitative and quantitative analysis of cerebrospinal fluid IgG: densitometric comparison of nephelometry-silver versus immuno-enzymes.
Keir G, Barrio S, Thompson EJ.
Ann Clin Biochem. 2008 Jul;45(Pt 4):404-8. doi: 10.1258/acb.2008.007056.
PMID:18583626
Quantitative Evaluation of Different Protein Fractions of Cerebrospinal Fluid Using (18)O Labeling.
Birke R, Krause E, Schümann M, Blasig IE, Haseloff RF.
Novel fluid biomarkers for mild cognitive impairment: A systematic review and meta-analysis.
Gaur A, Rivet L, Mah E, Bawa KK, Gallagher D, Herrmann N, Lanctôt KL.
Ageing Res Rev. 2023 Nov;91:102046. doi: 10.1016/j.arr.2023.102046. Epub 2023 Aug 28.
PMID:37647995
Cerebrospinal fluid pressure dynamics reveal signs of effective spinal canal narrowing in ambiguous spine conditions.
Kheram N, Pfender N, Boraschi A, Farshad M, Kurtcuoglu V, Curt A, Schubert M, Zipser CM.
Front Neurol. 2022 Aug 9;13:951018. doi: 10.3389/fneur.2022.951018. eCollection 2022.
PMID:36016547
Mass spectrometry-based proteomics of cerebrospinal fluid in pediatric central nervous system malignancies: a systematic review with meta-analysis of individual patient data.
Mirian C, Thastrup M, Mathiasen R, Schmiegelow K, Olsen JV, Østergaard O.
Fluids Barriers CNS. 2024 Feb 13;21(1):14. doi: 10.1186/s12987-024-00515-x.